ATP2B4 and breast cancer: This result further supports the idea that different ER-α positive breast cancer cell lines use different regulatory pathways in response to ER-α activation, and are in accordance with our results indicating that among the ER-α positive cell lines only MCF-7 is E2-responsive in terms of elevation of PMCA4b expression.